Carolina Torres Soares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carolina Torres Soares has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Maria Cappellano
Department of Pediatric Oncology, IOP-GRAACC-Federal University of Sao Paulo, Sao Paulo, Brazil
2 shared publications - Marcos Devanir Silva da Costa
Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil
2 shared publications - Sergio Cavalheiro
Universidade Federal de São Paulo, Brazil
2 shared publications Fernando Seiji Suzuki
1 shared publication- Frederico Adolfo Benevides Silva
Hospital Israelita Albert Einstein, Departamento de Radiologia, Seção de Neuroradiologia, São Paulo SP, Brazil
1 shared publication - Jardel Mendonça Nicácio
Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo- SP, Brazil
1 shared publication
Latest Publications
- 5 November 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 634
Risk factors associated with blood component transfusion in children undergoing surgical resection of intracranial tumors – a retrospective cohort study
- 5 November 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 634
Risk factors associated with blood component transfusion in children undergoing surgical resection of intracranial tumors – a retrospective cohort study
- 16 May 2024
- Published by Springer Nature
- p. 417-467
Pediatric Infratentorial Tumors’ Treatment in the Molecular Era
- 16 May 2024
- Published by Springer Nature
- p. 417-467
Pediatric Infratentorial Tumors’ Treatment in the Molecular Era
- Open Access
- 13 September 2023
- Published by Archives of Pediatric Neurosurgery in Archives of Pediatric Neurosurgery
- Vol. 5 (3) , e20102023
Posterior fossa ependymomas in children and adolescents - the state of the art
Central nervous system tumors in pediatric patients represent the most frequent solid tumor type in this age group, especially ependymomas, which comprise 5% of childhood intracranial tumors, and occur mainly in the posterior fossa. The MEDLINE and ClinicalTrials databases were searched for studies on posterior fossa ependymomas, 64 studies met the search criteria. Symptoms include ataxia, vertigo, headache, vomiting, cranial nerve palsies, or papilledema, resulting from intracranial hypertension due to obstruction of CSF circulation. Imaging examination often reveals posterior fossa ependymomas in the fourth ventricle or cerebellopontine angle; they may extend through the foramina of Luschka, Magendie, and/or magnum. These tumors cause a significant mass effect, displacing rather than invading the hidbrain, and may involve vessels or cranial nerves, making surgical resection difficult. Various radiological features have been studied to distinguish between ependymomas and other histological types, as well as between ependymoma subtypes. The 2021 WHO classification of central nervous system tumors classifies ependymomas by location. Three types occur in the posterior fossa: subependymomas, PF-A, and PF-B. These are differentiated by the degree of DNA methylation and CpG islands, which can be assessed by immunohistochemical analysis with H3K27me3. The consensus on the treatment of posterior fossa ependymomas in children advocates the maximum possible surgical resection, followed by radiotherapy in patients >1 year. Chemotherapy remains controversial, with no survival gain. Recent studies suggest molecular subgroups as an independent prognostic factor in posterior fossa ependymomas. The therapeutic challenge of ependymomas requires new treatment options, based on new technologies and molecular discoveries.
- 13 September 2023
- Published by Archives of Pediatric Neurosurgery in Archives of Pediatric Neurosurgery
- Vol. 5 (3) , e20102023
Open AccessPosterior fossa ependymomas in children and adolescents - the state of the art
Central nervous system tumors in pediatric patients represent the most frequent solid tumor type in this age group, especially ependymomas, which comprise 5% of childhood intracranial tumors, and occur mainly in the posterior fossa. The MEDLINE and ClinicalTrials databases were searched for studies on posterior fossa ependymomas, 64 studies met the search criteria. Symptoms include ataxia, vertigo, headache, vomiting, cranial nerve palsies, or papilledema, resulting from intracranial hypertension due to obstruction of CSF circulation. Imaging examination often reveals posterior fossa ependymomas in the fourth ventricle or cerebellopontine angle; they may extend through the foramina of Luschka, Magendie, and/or magnum. These tumors cause a significant mass effect, displacing rather than invading the hidbrain, and may involve vessels or cranial nerves, making surgical resection difficult. Various radiological features have been studied to distinguish between ependymomas and other histological types, as well as between ependymoma subtypes. The 2021 WHO classification of central nervous system tumors classifies ependymomas by location. Three types occur in the posterior fossa: subependymomas, PF-A, and PF-B. These are differentiated by the degree of DNA methylation and CpG islands, which can be assessed by immunohistochemical analysis with H3K27me3. The consensus on the treatment of posterior fossa ependymomas in children advocates the maximum possible surgical resection, followed by radiotherapy in patients >1 year. Chemotherapy remains controversial, with no survival gain. Recent studies suggest molecular subgroups as an independent prognostic factor in posterior fossa ependymomas. The therapeutic challenge of ependymomas requires new treatment options, based on new technologies and molecular discoveries.